Type: Session Therapeutic: Dermatology
Thursday May 10 4:45pm to 5:45pm Location: Lecture Hall 1 Credits: 1 Mainpro+
1. Contact dermatitis: Allergens of the year, where to get patch testing and why.
2. Drug reaction of the year: You see it but don’t know it. Hint: gliptins
3. Drug rashes, when to get worried. Hint: Fever.
4. Biologics for everything (and why)? Psoriasis
5. Biologics for everything (and why)? Atopic dermatitis
6. Biologics for everything (and why)? Hidaradenitis suppurativa
7. Hand dermatitis: Think patch testing, biologics, work-related, alitretinoin.
8. One word: CANCER: Keratinocyte carcinomas,
9. More CANCER: Merkel cell tumors, Melanoma
10. Wound healing: Leg ulcers are helped by compression
Dermatitis can be helped most when we know the correct type: atopic, contact, hand dermatitis are 3 examples.
Skin cancers are on the rise and we can treat them medically and surgically. The main killers are melanoma and Merkel cell tumours. “If tumour is the rumour. Tissue is the issue.”
Drug rashes can be catogarized and managed by thinking of the appearance of the rash and the presence of fever.
Neil Shear MD, FRCPC, FACP Dr. Neil Shear graduated with a degree in Engineering Science from the University of Toronto in 1973 and earned his medical degree at McMaster University, Hamilton, in 1976. Dr. Shear then completed training in both internal medicine and dermatology recognized by the Royal College of Physicians and Surgeons of Canada and the American Boards. He also completed a fellowship in Clinical Pharmacology, supported by the Medical Research Council of Canada, at the Hospital for Sick Children in Toronto. Dr. Shear joined Sunnybrook Hospital in Toronto in 1984 and is now the Head of Dermatology at Sunnybrook Health Sciences Centre. Dr Shear founded the Drug Safety Clinic at Sunnybrook in 1985 and was the founding chair of the Canadian Adverse Drug Reaction Advisory Committee (CADRAC) of Health Canada.
Dr. Shear has conducted numerous clinical trials in dermatology, from first in human early pharmacology studies to large randomized trials of novel therapeutics, and he is Vice President of Research and Development (Dermatology) at Ventana Clinical Research. His research has been funded by numerous peer-reviewed agencies and the pharmaceutical industry. Dr. Shear’s main interest is in idiosyncratic drug reactions that involve the skin. He has published over 350 peer-reviewed papers and numerous chapters and abstracts. His clinical interests are diverse, from rosacea and camouflage makeup to autoimmune blistering diseases. Dr. Shear is a past president of the Canadian Society for Clinical Pharmacology and a recipient of the society’s Distinguished Service Award. He is the former University Division Director of Dematology at the University of Toronto, former Chair of the Canadian Association of Professors of Dermatology, Past-President of the Canadian Dermatology Foundation, and President-Elect of the Canadian Dermatology Association. He was the founding editor of the Canadian Journal of Clinical Pharmacology and is an associate editor of the Journal of Cutaneous Medicine and Surgery.